Takeda CEO confident of investor backing for $62 bil Shire deal

The boss of Japan's Takeda Pharmaceutical says he is confident of securing investor backing for its $62 billion acquisition of London-listed Shire, despite some shareholders' fears about the…

 
More Headlines

Follow worldbiztoday on Twitter

US Stocks